|
Volumn 3, Issue 4, 2004, Pages 249-251
|
Determination of tobramycin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis
|
Author keywords
Cystic fibrosis; Saliva; Therapeutic drug monitoring; Tobramycin
|
Indexed keywords
TOBRAMYCIN;
ADOLESCENT;
ANALYZER;
ARTICLE;
AUSTRALIA;
BLOOD SAMPLING;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CYSTIC FIBROSIS;
DRUG BLOOD LEVEL;
DRUG DOSE REGIMEN;
DRUG INFUSION;
DRUG MONITORING;
DRUG SALIVA LEVEL;
FEMALE;
GRAM NEGATIVE INFECTION;
HUMAN;
MALE;
PEDIATRIC HOSPITAL;
SAMPLER;
SCHOOL CHILD;
ADOLESCENT;
ANTI-BACTERIAL AGENTS;
CHILD;
CYSTIC FIBROSIS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG MONITORING;
FEMALE;
HUMANS;
INJECTIONS, INTRAVENOUS;
LUNG DISEASES;
MALE;
NEPHELOMETRY AND TURBIDIMETRY;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTIONS;
SALIVA;
TOBRAMYCIN;
|
EID: 13644255949
PISSN: 15691993
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jcf.2004.08.003 Document Type: Article |
Times cited : (13)
|
References (11)
|